PET imaging with 18F-florbetaben IDs Alzheimer's

04/2/2013 | MolecularImaging.net

Uptake of 18F-florbetaben on PET imaging scans was higher in the cerebral cortex of patients with Alzheimer's disease than in healthy study participants, according to a study published in the Journal of Nuclear Medicine. Researchers used a kinetic compartment theory of analysis for this study. "Compartment kinetic model-based quantification of [beta-amyloid] binding from 18F-florbetaben PET data is feasible, and all [beta-amyloid] binding parameters, including those by the reference tissue model and the practically useful SUVR, are excellent in discriminating between beta-amyloid–positive–and–negative scans," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC